marketbeat.com

B. Metzler Sohn & Co. AG Lowers Position in Edwards Lifesciences Stock

Edwards Lifesciences logoEdwards Lifesciences
Sig1.55Sen+2.25Env0.00Soc0.00Gov0.00

The institutional investor held 41,753 Edwards Lifesciences shares after selling 14,264 during the quarter. Quadrant Capital Group now owns 15,113 shares worth $1.288 million after buying 136 shares, and Covestor owns 1,784 shares valued at $152,000 after buying 157. Edwards Lifesciences reported quarterly EPS of $0.78, topping the $0.74 consensus.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro